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ABSTRACT
Aim: We aimed to compare modifiable cardiometabolic risk factors among treatment-
seeking adolescents with obesity in Italy, Germany and Norway.
Methods: This retrospective, registry-based, cross-sectional cohort study included 2,327
(59% girls) 12–18 year-old adolescents with obesity from three tertiary care outpatient
clinics in Europe, between 1999 and 2015. The prevalence of cardiometabolic risk factors
was compared between clinics, and multivariate logistic regression models including
gender, age, waist circumference and body mass index were used to assess the
associations between population and cardiometabolic risk.
Results: In total, 1,396 adolescents (60% girls) from Italy, 654 (58% girls) from Germany
and 277 (51% girls) from Norway were included. The mean  SD age was
15.2  1.6 years, body mass index 38.8  6.5 kg/m2 and body mass index standard
deviation score 3.21  0.43. The prevalence of elevated nonhigh-density lipoprotein-
cholesterol in Norway, Germany and Italy was 60%, 54% and 45%, while the prevalence
of high systolic or diastolic blood pressure (≥130 or ≥85 mmHg) were 15%, 46% and
66%, respectively.
Conclusion: Cardiometabolic risk factors among treatment-seeking adolescents with
obesity from Italy, Germany and Norway differed across the populations in this study, which
might imply that preventive clinical work should reflect such differences.
INTRODUCTION
Childhood obesity has reached epidemic proportions
worldwide (1). During childhood and adolescence, obesity
in general, and abdominal obesity in particular, is associ-
ated with increased levels of cardiovascular risk factors,
such as serum triglycerides, low-density lipoprotein-choles-
terol (LDL-C) and decreased high-density lipoprotein-
cholesterol (HDL-C). Being obese is also associated with
dysglycaemia and high blood pressure. All these factors are
independent risk factors for cardiovascular disease (2). An
unhealthy diet has been associated with obesity, dyslipi-
demia, dysglycaemia and high blood pressure, whilst weight
loss, healthy diets and physical activity may improve these
risk factors (3). In addition, geographic, genetic, cultural
and lifestyle differences may influence the cardiometabolic
effects of severe obesity (4,5).
During the last decade, it has been suggested that
elevated nonhigh-density lipoprotein-cholesterol (non
Abbreviations
BMI, Body mass index; BMI SDS, Body mass index standard
deviation score; BP, Blood pressure; HDL-C, High-density
lipoprotein-cholesterol; LDL-C, Low-density lipoprotein-choles-
terol; SD, Standard deviation.
Key notes
 Cardiometabolic risk factors might differ across popu-
lations; we investigated 2,327 treatment-seeking ado-
lescents with obesity from Italy, Germany and Norway.
 The prevalence of elevated nonhigh-density lipopro-
tein-cholesterol was highest among Norwegians (60%)
and lowest among Italians (45%), while high blood
pressure was most common in the German (66%) and
lowest in the Norwegian (15%) cohort.
 Our findings suggest that preventive clinical work
should reflect such differences in cardiometabolic risk
factors across populations.
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HDL-C), containing all the atherogenic particles, may be a
stronger predictor of morbidity and mortality from cardio-
vascular disease than elevated LDL-C (6). Nonetheless,
elevated LDL-C is a major causal risk factor for cardiovas-
cular disease in adults, and it has been demonstrated that
lowering LDL-C reduces the risk of cardiovascular disease
(7). In a clinical report from 2017, the American Academy
of Pediatrics recommended shifting the focus in youths
from metabolic syndrome, a cluster of metabolic risk factors
(8), to single specific risk factors, such as hypertension and
LDL-C (9).
We aimed to assess regional differences in south, middle
and north of Europe in the prevalence of specific car-
diometabolic risk factors; defined as elevated levels of LDL-
C, non HDL-C and triglycerides, dysglycaemia, elevated
blood pressure and metabolic syndrome, in treatment-
seeking Italian, German and Norwegian adolescents with
moderate to severe obesity. We hypothesised that the
prevalence of specific cardiometabolic risk factors among
adolescents seeking treatment for obesity differed between
these countries.
MATERIALS AND METHODS
Design, setting and participants
This study was a collaborative project between three tertiary
obesity clinics in Italy, Germany and Norway, comparing
three registry-based cohorts of adolescents (12–18 years)
with obesity using a retrospective, cross-sectional design.
The investigators agreed on prespecified research questions
(hypotheses), which could be tested by using the available
data.
The patients were referred to the obesity clinics by
primary care paediatricians or general practitioners. Ado-
lescents with moderate to severe obesity (10), and with
complete data on age, gender, body mass index (BMI),
LDL-C, non HDL-C and components of metabolic syn-
drome (8); waist circumference, systolic and diastolic blood
pressure (systolic BP and diastolic BP), triglycerides, HDL-
C and fasting plasma glucose recorded, were included into
the study.
The Italian cohort consisted of 1396 (60% female)
adolescents referred to the Division of Auxology, Istituto
Auxologico Italiano, Verbania, between 2010 and 2013.
The German cohort consisted of 654 (58% female)
adolescents referred to Adipositas Reha-Klinik Insula,
Bischofswiesen, Oberbayern, in the period 1999 to 2008.
The Norwegian cohort included 277 adolescents (51%
female), referred to the Morbid Obesity Centre, Vestfold
Hospital Trust, Tønsberg, from 2009 to 2015.
Data sources and measurements
An overview is presented in Table S1. Height was measured
to the nearest 0.1 cm using a Harpenden stadiometer
(Holtain, Pembrokeshire, UK) in Italy and Germany, and
a Heightronic Digital Stadiometer (QuickMedical, Wash-
ington, DC, USA) in Norway. Weight (kg) was measured by
a Salus electronic scale (Salus Vandoni Srl, Gaggiano, Italy)
in the Italian and German cohorts. In the Norwegian
cohort, weight was measured using a Tanita BC-418
bioimpedance body composition analyser (Tanita Corp.,
Tokyo, Japan). Waist circumference was measured using a
standardised anthropometric tape, measuring the circum-
ference at the midpoint between the iliac crest and the
lower part of the lateral rib cage (cm). BMI was calculated
as weight (kg)/height (m)2, and converted to age- and sex-
adjusted BMI standard deviation score (BMI SDS) accord-
ing to the reference from the International Obesity Task
Force (10). BMI was also classified into overweight, obesity
or severe obesity according to the International Obesity
Task Force definitions; BMI corresponding to a BMI of
≥25–29, ≥30–34 or ≥35 kg/m2 at age 18 (10).
Blood pressure measurements
The Italian cohort measured systolic and diastolic BP twice
on the dominant arm in the sitting position with an aneroid
sphygmomanometer (Tema Certus, Milan, Italy), by using
appropriate sized cuffs after the patient had rested for at
least 15 minutes. The mean values were calculated and
rounded to the nearest 5 mmHg value.
The German adolescents had their BP measured twice
aneroidly (Bosch und Sohn boso medicus control, Junin-
gen, Germany) in a sitting position at least five minutes after
arriving in the medical department, using large cuff sizes on
the mid-upper dominant arm. The mean values were
calculated.
In Norway, BP was measured using a Dinamap ProCare
digital oscillometric device (GE Healthcare, Bucking-
hamshire, UK). BP measurements were performed in the
sitting position using appropriate sized cuffs (the mid-upper
arm circumference was measured) four times on the
dominant arm, and the average of the three last measure-
ments was calculated.
Metabolic measurements
Venous blood samples were collected after an overnight
fast. In Italy and Germany, the analyses were done using
Cobas Hitachi enzymatic colorimetric assays (Roche Diag-
nostics Gmbh, Mannheim, Germany). In Norway, the
analyses were performed immediately thereafter by layered
dry-slide chemical methods with photometric reflection and
potentiometric detection principles using Vitros Microslide
Technology (Ortho-Clinical Diagnostics, Buckinghamshire,
UK).
Definition of cardiometabolic risk factors and MetS
LDL-C was calculated using the Friedewald equation; LDL-
C = total cholesterol – HDL-C – triglycerides/2.2. Non
HDL-C (mmol/L) was calculated as total-cholesterol minus
HDL-C. Participants were classified as having elevated
values (yes/no) of LDL-C and non HDL-C according to
thresholds of ≥2.8 mmol/L and ≥3.1 mmol/L (11). Meta-
bolic syndrome was defined according to the International
Diabetes Federation criteria (8). The first criterion (manda-
tory) is abdominal obesity, waist circumference ≥90th
percentile or adult cut-off if lower (12). In addition, at least
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two of the other four criteria regarding BP, triglycerides,
HDL-C and fasting plasma glucose had to be fulfilled.
Participants were classified as having elevated BP if they
had systolic BP ≥130 or diastolic BP ≥85 mmHg and
elevated plasma glucose if fasting plasma glucose
≥5.6 mmol/L. High triglycerides and low HDL-C were
defined as ≥1.7 mmol/L or <1.03 mmol/L (<1.29 mmol/L
for females ≥16 years), respectively (8).
Ethical considerations
Parents or legal tutors of the participants signed a written
informed consent. The study was approved by the Ethical
Committee of Istituto Auxologico Italiano, IRCCS, Milan,
Italy (ref. 01C630), the local Ethical Committee at Adiposi-
tas Reha Klinik Insula, Bischofswiesen, Oberbayern, Ger-
many and by the Regional Committee for Medical and
Health Research Ethics of South-East Norway (2015/
2415). Within the Norwegian cohort, adolescents and their
parents provided written informed consent allowing inclu-
sion into the Vestfold Childhood Obesity Registry upon
engaging in treatment (Regional Ethics Committee approval
number S-08742c 2008/19081). Written informed consent
was provided from all participants, and the study was
performed in accordance with the Declaration of Helsinki.
Statistical analyses
Crude differences between groups regarding continuous
and categorical variables were assessed using one-way
ANOVA or chi-square test. In addition, mean standardised
differences, Cohen‘s d, were calculated.
Comparisons between the cohorts in regards to the
prevalence of elevated LDL-C and non HDL-C levels,
metabolic syndrome and its components were performed
using chi-square tests. In addition, univariate and multi-
variate logistic regression models were used to estimate
possible associations between nationality – Italian or
German, using Norwegian as the reference category due
to the lowest prevalence metabolic syndrome – and the
main outcomes, elevated LDL-C and non HDL-C, and
metabolic syndrome and its components. The final multi-
variate analysis was adjusted for gender, using girls as the
reference category, age (years), waist circumference (cm)
and BMI (kg/m2).
The goodness of fit was tested using the Hosmer and
Lemeshow test. This study is considered exploratory;
therefore, no correction for multiple testing was performed
and p-values <0.05 were considered statistically significant.
All analyses were performed with SPSS version 21.0 (IBM
Corp., Armonk, New York, USA).
RESULTS
Complete datasets for analysis were available from 98%,
91% and 72% of the Italian, Norwegian and German
cohorts, respectively (Fig. 1). Demographic, clinical and
biochemical characteristics are shown in Table 1. The mean
age differed slightly between the cohorts (14.9–15.3 years),
and more than half (59%) of the total cohort were female,
with the lowest proportion (51%) in the Norwegian cohort.
The German adolescents had higher mean measures of
Figure 1 The exclusion process for the Italian, German and Norwegian cohorts. *One person can be missing more than one type of data value.
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BMI-SDS and waist circumference when compared with
their Italian and Norwegian counterparts and nearly all
adolescents fulfilled the metabolic syndrome criterion for
abdominal obesity. The proportions of adolescents with
BMI above the IOTF-35 threshold of severe obesity were
74% in the Italian, 85% in the German and 83% in the
Norwegian cohort. Mean systolic and diastolic BP values
were highest in the German cohort (133 and 81 mmHg),
and lowest in the Norwegian cohort (116 and 61 mmHg).
The mean values of fasting plasma glucose, total-choles-
terol, HDL-C and triglycerides differed significantly
between the cohorts; effect sizes ranging from 0.1 to 0.8
for differences (Table 1), with the lowest mean value found
in the Italian cohort. The mean LDL-C levels did not differ
among the cohorts.
The proportions of adolescents with elevated LDL-C
(42%) did not differ significantly among the cohorts. The
prevalence of elevated non HDL-C was highest in Norway
(60%) and lowest in Italy (45%). The prevalence of
metabolic syndrome was higher in the German cohort
(40%) than in the Italian and Norwegian cohorts (26% and
24%, respectively) (Table 1). The proportions of adoles-
cents fulfilling the glucose, triglyceride and blood pressure
components of metabolic syndrome were 0.4%, 10.0% and
46% (Italy), 6.4%, 24.0% and 65.7% (Germany) and 3.6%,
33.9% and 15.2% (Norway; Table S2).
Table 2 and Figure 2 show the unadjusted (model 1) and
adjusted (models 2–5) odds ratios (ORs) for elevated LDL-
C and non HDL-C levels, elevated blood pressure and
metabolic syndrome according to nationality. As compared
with the Norwegian cohort, the Italian adolescents had
significantly lower unadjusted odds for elevated non HDL-
C (OR: 0.6, 95% CI: 0.4–0.7) and increased odds for
elevated BP (4.8, 95% CI: 3.4–6.7), both which remained
nearly unchanged after multivariate adjustments for gender,
age, waist circumference and BMI. The German adoles-
cents had ten-fold higher unadjusted odds for elevated BP
(OR: 10.7, 95% CI: 7.5–15.5) compared with the Norwegian



















Gender, female (%) 840 (60.2) 382 (58.4) 142 (51.3) 1,364 (58.6) 0.023
Age, years 15.3 (1.6) 15.2 (1.5) 14.9 (1.7) 15.2 (1.6) <0.001 0.31 0.24 0.08
Anthropometric data
Weight, kg 103.9 (21.2) 118.1 (24.0) 109.2 (22.1) 108.5 (23.0) <0.001 1.15 1.83 2.96
Height, m 1.64 (0.09) 1.71 (0.09) 1.68 (0.09) 1.67 (0.09) <0.001 0.13 0.10 0.23
BMI, kg/m2 38.1 (6.1) 40.4 (7.1) 38.6 (6.0) 38.8 (6.5) <0.001 0.20 0.69 0.90
BMI SDS, IOTF reference 3.15 (0.43) 3.31 (0.43) 3.23 (0.37) 3.21 (0.43) <0.001 0.12 0.12 0.24
Waist circumference, cm 114.6 (14.8) 122.4 (15.9) 112.0 (12.7) 116.5 (15.4) <0.001 0.68 2.62 1.97
BMI classification according to IOTF*
Overweight (%) 5 (0.4) 8 (1.2) – 13 (0.6) <0.001
Obesity (%) 357 (25.6) 88 (13.5) 48 (17.3) 493 (21.2)
Severe obesity (%) 1,034 (74.1) 558 (85.3) 229 (82.7) 1,821 (78.3)
Cardiometabolic risk factors
Systolic BP 126 (12) 133 (17) 116 (15) 127 (15) <0.001 2.75 4.03 1.86
Diastolic BP 78 (8) 81 (13) 61 (7) 77 (11) <0.001 5.40 5.25 0.96
Fasting plasma glucose, mmol/L 4.3 (0.4) 4.8 (0.8) 4.9 (0.7) 4.5 (0.6) <0.001 0.83 0.11 0.63
Total-cholesterol, mmol/L 4.2 (0.8) 4.4 (0.9) 4.5 (0.8) 4.3 (0.8) <0.001 0.33 0.11 0.22
HDL-cholesterol, mmol/L 1.1 (0.3) 1.2 (0.3) 1.2 (0.3) 1.2 (0.3) 0.026 0.19 0.00 0.19
LDL-cholesterol, mmol/L 2.7 (0.7) 2.7 (0.8) 2.6 (0.7) 2.7 (0.8) 0.290 0.12 0.11 0.00
Non HDL-cholesterol, mmol/L 3.1 (0.8) 3.3 (0.8) 3.3 (0.8) 3.1 (0.8) <0.001 0.22 0.00 0.22
Triglycerides, mmol/L 1.1 (0.5) 1.4 (0.7) 1.5 (0.8) 1.2 (0.6) <0.001 0.53 0.12 0.40
Elevated non HDL-cholesterol,
% (95% CI)**
44.9 (42.3–47.6) 54.4 (50.5–58.3) 59.6 (53.7–65.5) 49.3 (47.2–51.4) <0.001
Elevated LDL-cholesterol,
% (95% CI)**
42.6 (40.4–45.3) 40.4 (36.5–44.2) 40.4 (34.4–46.3) 41.7 (39.7–43.8) 0.56
Elevated BP, % (95% CI) 46.0 (43.3–48.7) 65.7 (62.0–69.5) 15.2 (10.9–19.5) 47.9 (45.8–49.9) <0.001
Metabolic syndrome,
% (95% CI)
26.4 (24.0–28.7) 39.6 (35.9–43.4) 24.2 (19.1–29.2) 29.8 (28.0–31.7) <0.001
Statistics are ANOVA for continuous and chi-square test for categorical variables.
*Classification of body mass index according to the International Obesity Task Force.
**Elevated LDL-C (low-density lipoprotein-cholesterol) is defined as values ≥2.8 mmol/L, elevated non HDL-C (non-high-density lipoprotein-cholesterol) is
defined as values ≥3.1 mmol/L.
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cohort, which remained nearly unchanged after multi-
variate adjustments.
DISCUSSION
This study of treatment-seeking adolescents with obesity
confirmed the hypothesis that the prevalence of clinically
important cardiometabolic risk factors differed between
three European countries. First, the prevalence of elevated
non HDL-C was highest in Norway (60%) and lowest in
Italy (45%), and, accordingly, Italian adolescents had
lower adjusted odds (OR: 0.5, 95% CI: 0.4–0.7) for
elevated non HDL-C levels, as compared with their
Norwegian counterparts. Second, the prevalence of ele-
vated blood pressure was highest in Germany (66%) and
lowest in Norway (15%), and German and Italian adoles-
cents had higher adjusted odds for elevated blood pres-
sure, OR 11 (95% CI: 8–17) and OR 6 (95% CI: 4–8) as
Table 2 Multivariate analyses of cardiovascular risk factors, total population
LDL-cholesterol Non HDL-cholesterol Elevated blood pressure Metabolic syndrome
OR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P
Model 1
Nationality
Norwegian Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
German 1.00 0.75–1.33 1.00 0.81 0.61–1.08 0.14 10.74 7.45–15.49 <0.001 2.06 1.50–2.82 <0.001
Italian 1.10 0.88–1.43 0.49 0.55 0.43–0.72 <0.001 4.76 3.38–6.73 <0.001 1.12 0.83–1.51 0.45
Model 2
Nationality
Norwegian Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
German 1.01 0.76–1.35 0.93 0.82 0.62–1.09 0.17 11.87 8.19–17.20 <0.001 2.14 1.55–2.94 <0.001
Italian 1.12 0.86–1.45 0.42 0.56 0.43–0.73 <0.001 5.22 3.68–7.40 <0.001 1.17 0.86–1.58 0.31
Gender
Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Male 1.21 1.02–1.43 0.03 1.18 1.00–1.39 0.051 1.92 1.61–2.28 <0.001 1.54 1.28–1.84 <0.001
Model 3
Nationality
Norwegian Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
German 1.01 0.76–1.35 0.93 0.81 0.61–1.08 0.15 11.70 8.06–17.0 <0.001 2.05 1.48–2.82 <0.001
Italian 1.12 0.86–1.46 0.41 0.55 0.43–0.72 <0.001 4.96 3.49–7.04 <0.001 1.06 0.78–1.44 0.72
Gender
Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Male 1.20 1.02–1.42 0.03 1.19 1.01–1.41 0.042 2.01 1.68–2.41 <0.001 1.65 1.37–1.98 <0.001
Age (year) 1.00 0.95–1.05 0.88 1.03 0.98–1.09 0.23 1.19 1.13–1.26 <0.001 1.28 1.21–1.36 <0.001
Model 4
Nationality
Norwegian Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
German 0.98 0.73–1.31 0.87 0.75 0.56–1.00 0.048 9.17 6.27–13.40 <0.001 1.46 1.05–2.05 0.027
Italian 1.11 0.85–1.44 0.45 0.54 0.42–0.71 <0.001 4.82 3.38–6.87 <0.001 0.97 0.71–1.32 0.84
Gender
Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Male 1.17 0.98–1.39 0.09 1.11 0.93–1.32 0.26 1.56 1.29–1.88 <0.001 1.23 1.01–1.50 0.04
Age (year) 0.99 0.94–1.04 0.64 1.01 0.96–1.07 0.67 1.11 1.05–1.18 <0.001 1.19 1.11–1.26 <0.001
Waist (cm) 1.00 1.00–1.01 0.22 1.01 1.00–1.01 0.006 1.03 1.03–1.04 <0.001 1.04 1.03–1.04 <0.001
Model 5
Nationality
Norwegian Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
German 0.97 0.72–1.31 0.84 0.73 0.54–0.98 0.037 11.20 7.58–16.54 <0.001 1.52 1.08–2.13 0.016
Italian 1.10 0.84–1.44 0.47 0.53 0.41–0.70 <0.001 5.68 3.95–8.16 <0.001 1.00 0.73–1.37 0.99
Gender
Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Male 1.16 0.96–1.39 0.12 1.08 0.90–1.30 0.41 1.86 1.52–2.27 <0.001 1.28 1.04–1.58 0.018
Age (year) 0.99 0.94–1.04 0.65 1.01 0.96–1.07 0.64 1.10 1.04–1.17 0.001 1.19 1.11–1.26 <0.001
Waist (cm) 1.01 1.00–1.01 0.34 1.01 1.00–1.02 0.015 1.01 1.00–1.02 0.24 1.03 1.02–1.04 <0.001
BMI (kg/m2) 1.00 0.98–1.02 0.81 0.99 0.97–1.01 0.35 1.08 1.06–1.11 <0.001 1.02 0.99–1.04 0.17
OR = odds ratio; 95% CI = 95% confidence intervals.
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compared with their Norwegian counterparts (Table 2,
Fig. 2).
A south-north gradient was revealed in the case of non
HDL-C and triglyceride levels, which were found to be
highest in Norway and lowest in Italy. There were, however,
no statistically significant differences among the cohorts
regarding the prevalence of elevated LDL-C (40–43%,
Table 1); while a larger proportion of Italian adolescents
had low HDL-C levels (Table S2).
Possible reasons for regional differences
The revealed differences in dyslipidemia and blood pressure
might have several explanations. Regional differences in
diet, for example salt intake (13), and the traditional
Mediterranean-style diet (14), might have affected meta-
bolic risk factors – such as blood pressure and blood lipids.
The same risk factors might also have been influenced by
differences in physical activity levels (11,15). Regional
differences have been demonstrated in favour of Northern-
Central versus Southern Europe with regards to physical
activity and sedentary time among the general adolescent
populations (16,17). An international, survey-based, report
from the WHO from 2013/2014 on Health Behaviour in
school-aged children, showed that 75% of Norwegian 15-
year olds engaged vigorous physical activity ≥2 hours a
week, versus 52% in Italy and 64% in Germany, and 32%
had a daily intake of vegetables, versus 29% in Italy and
24% in Germany. Fewer Norwegian 15-year olds reported
daily intake of sweets, 7% in Norway, 27% in Italy and 26%
in Germany, although 74% of Norwegian and 66% of
German adolescents reported spending ≥2 hours per week-
day using a computer during their spare time, somewhat
more frequently than the 55% of their Italian 15-year old
counterparts (17). An Italian study of 9–11-year-old chil-
dren reported that 88% used olive oil as a condiment when
eating at home (18). Vegetable oils contain phytosterols,
which can have beneficial effects on blood lipids. The
intake is on average 250 mg/day in Northern Europe
compared to approximately the double in Mediterranean
countries for adults (19). However, it should be noted that
the above-mentioned studies were based on adolescents in
the general population, and the same tendencies might not
apply to adolescents with obesity.
High sodium intake increases the risk of hypertension
(13). Adolescents with obesity have greater BP sensitivity to
sodium intake than adolescents with a normal range weight.
The relative hyperinsulinemia associated with obesity can
contribute to upregulate renal tubular sodium transport,
and hence increase the sodium reabsorption in the distal
tubules and increase BP (20). Salt intake among German
14–18-year-olds was 6.2 g/day for girls and 8.2 g/day for
boys (21). In comparison, a recent Norwegian study of 13-
year olds, reported a mean salt intake of 5.8 g/day for girls
and 6.8 g/day for boys (22), and an Italian study group
Figure 2 Unadjusted (circles) and adjusted (squares) odds ratio with 95% confidence intervals for having elevated LDL-cholesterol (≥2.8 mmol/L), non HDL-cholesterol
(≥3.1 mmol/L), elevated blood pressure (systolic BP ≥130 or diastolic BP≥85 mmHg) and metabolic syndrome among the cohorts of adolescents from Italy and
Germany. Norway is used as the reference category. *p < 0.001, **p < 0.05.
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reported a mean daily salt intake of 6.7 g/day for girls and
7.4 g/day for boys aged between 7 and 18 years, with a
trend towards higher values in adolescents (23).
The high blood pressure levels observed in the present
study in the German cohort were in line with a European
health interview survey, which reported higher prevalence
of hypertensive diseases in the population aged 15 years
and over in Germany (28.5%) than in Norway (12.7%) and
Italy (20.6%) (24). A study published in 2017 also showed a
very high frequency of elevated BP in German adolescents
with obesity (25), although using different cut-off values
than this study. Our findings of lowest prevalence of
metabolic syndrome in the Norwegian cohort are also in
consistence with an international comparison that showed
children from Germany in the highest cardiovascular risk
tertile, Italy in the middle and children from Norway in the
tertile with most favourable cardiovascular risk profile
overall (5).
The Norwegian adolescents had high levels of triglyc-
erides. This might be a result of a high intake of refined
sugar or a diet high in saturated fat or trans fat (19), which
may lead to an increase in visceral fat and triglyceride levels
(19).
Strengths and limitations
One strength of this study was the measurement of
specific cardiovascular risk factors, atherogenic lipids and
high blood pressure, rather than metabolic syndrome, a
composite risk factor. This might possibly have provided a
more valid estimate of cardiovascular health (2,9). Similar
laboratory assays were used in Germany and Italy
(Table S1). Although different assays were used to analyse
the samples from the Norwegian cohort, the Norwegian
laboratory changed their method to the one used in Italy
and Germany after completion of the current study, and
validation analyses showed that these assays were com-
parable. However, this study had some limitations that
need to be addressed. First, the cross-sectional design
does not allow for drawing conclusions about causality.
Second, heterogeneity in the measuring techniques of BP
might have biased the results. The Italian and German
cohorts had their BP measured twice and averaged, while
the Norwegians had their BP measured four times, and
the last three readings were averaged. This is likely to
have affected the Norwegian BPs to be lower on average
than their European counterparts, as each of three
consecutive BP measurement in children with overweight
have been shown to be lower than the previous one, with
the third measurement being on average 4.3 and
2.6 mmHg lower for systolic BP and diastolic BP than
the first one, respectively (26). Further, BP was measured
with aneroid manual sphygmomanometers (auscultation)
in Italy and Germany, whereas in Norway an automated
oscillometric device (measures vibrations in the artery
wall and converts the measurements into electrical
signals) was used. Oscillometric devices in general sys-
tematically overestimate systolic BP, and might also
overestimate diastolic BP compared with values obtained
with auscultation (13,27). In best case, these flaws in
different directions might have neutralised each other to
some degree. Third, age, body weight and gender balance
differed slightly between clinics, but multivariate analyses
were implemented to adjust for these differences. Fourth,
the German cohort had a lower percentage of complete
datasets for analysis, which could have biased the results.
Fifth, objective measures of physical activity and nutri-
tional intake were not assessed, which limits the inter-
pretation of the findings.
Finally, the cohorts were measured at different time
periods; the German cohort was examined from 1999 to
2008, while the Italian and the Norwegian cohorts were
examined between 2010 and 2013 and between 2009 and
2015, respectively. Both changes in dietary components and
patterns, physical activity, sleep patterns and prevalence of
obesity among adolescents might have occurred during this
time period, and thereby might have biased the results.
IMPLICATIONS FOR PRACTICE
Conservative treatment of adolescents with obesity is
difficult, and it often has small or negligible effects on
body weight (28). However, even a small weight reduction
of 5–10%, improves cardiovascular risk factors in adults
(19), and small changes in BMI SDS may improve blood
pressure, triglycerides and LDL-C levels in children and
adolescents (29). For those not able to reduce their
overweight, it might also be helpful to address elevated
blood pressure or dyslipidemia in other ways than just
focusing on BMI, helping to reduce and postpone the
future burden of disease. In this study, the German and
Italian adolescents showed a worryingly high prevalence of
elevated blood pressure, while the Norwegian adolescents
had a high prevalence of elevated non HDL-C. To reduce
blood pressure, it is recommended to eat a diet rich in
fruits and vegetables, whole grains and lean proteins, and
to reduce the intake of saturated fat, sugar-sweetened
beverages and salt (13,20). To reduce dyslipidemia, reduc-
ing the intake of total and saturated fat, minimising intake
of trans fat, and reducing intake of added sugars to below
10% of daily energy consumption is recommended, as is
increasing the intake of vegetables, legumes, fruits, nuts,
fish (especially oily) and whole grains (19). Finally,
engaging in more physical activity (13,19), – especially
high-intensity interval training has been shown to be
beneficial for cardiorespiratory fitness (30), while having
a regular sleep pattern (31) may be beneficial for both high
BP and dyslipidemia.
CONCLUSION
The current study revealed significant differences in blood
pressure and non HDL-C levels among European adoles-
cents seeking treatment for obesity. The Norwegian cohort
had the highest prevalence of elevated non HDL-C (60%),
followed by Germany (54%) and Italy (45%). The preva-
lence of high blood pressure was higher in the German
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cohort (66%) than in the Italian (46%) and Norwegian
(15%) cohorts. These findings suggest that cardiometabolic
risk factors among adolescents with obesity might differ
across populations, which might imply that preventive
clinical work should reflect such differences.
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Table S1 Details of measurements in the three cohorts.
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components.
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